274 related articles for article (PubMed ID: 20476848)
1. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
Poulsen SA
Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
Nocentini A; Supuran CT
Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
[TBL] [Abstract][Full Text] [Related]
3. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
Monti SM; Supuran CT; De Simone G
Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
Lomelino C; McKenna R
Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
[TBL] [Abstract][Full Text] [Related]
5. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
6. Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
Lopez M; Bornaghi LF; Innocenti A; Vullo D; Charman SA; Supuran CT; Poulsen SA
J Med Chem; 2010 Apr; 53(7):2913-26. PubMed ID: 20201556
[TBL] [Abstract][Full Text] [Related]
7. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
Aggarwal M; McKenna R
Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: an editorial.
Supuran CT
Expert Opin Ther Pat; 2013; 23(6):677-9. PubMed ID: 23461558
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
Supuran CT
Nat Rev Drug Discov; 2008 Feb; 7(2):168-81. PubMed ID: 18167490
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
Supuran CT; Winum JY
Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
[TBL] [Abstract][Full Text] [Related]
11. Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1.
Winum JY; Capasso C
Expert Opin Ther Pat; 2013; 23(6):757-60. PubMed ID: 23441861
[TBL] [Abstract][Full Text] [Related]
12. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).
Carta F; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):681-91. PubMed ID: 23488823
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitors: a survey of recent patent literature.
Galons H; Oumata N; Meijer L
Expert Opin Ther Pat; 2010 Mar; 20(3):377-404. PubMed ID: 20180621
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrases as targets for medicinal chemistry.
Supuran CT; Scozzafava A
Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
16. Anti-infective carbonic anhydrase inhibitors: a patent and literature review.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):693-704. PubMed ID: 23488877
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of carbonic anhydrase IX: a new strategy against cancer.
Winum JY; Scozzafava A; Montero JL; Supuran CT
Anticancer Agents Med Chem; 2009 Jul; 9(6):693-702. PubMed ID: 19601749
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
Supuran CT
Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
[TBL] [Abstract][Full Text] [Related]
19. Recent patents in the discovery of small molecule inhibitors of JAK3.
Wilson LJ
Expert Opin Ther Pat; 2010 May; 20(5):609-23. PubMed ID: 20402545
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature.
Dai Y
Expert Opin Ther Pat; 2010 Jul; 20(7):885-97. PubMed ID: 20509775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
